Published in Am J Epidemiol on November 13, 2006
Cardiac remodeling in obesity. Physiol Rev (2008) 2.95
Adiponectin and risk of coronary heart disease in older men and women. J Clin Endocrinol Metab (2008) 2.65
Metabolic changes during gonadotropin-releasing hormone agonist therapy for prostate cancer: differences from the classic metabolic syndrome. Cancer (2008) 2.16
Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK. J Am Soc Nephrol (2010) 1.75
Adipocytokines, obesity, and insulin resistance during combined androgen blockade for prostate cancer. Urology (2008) 1.53
Adiponectin and cardiovascular health: an update. Br J Pharmacol (2012) 1.42
Sex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease: the Mayo Clinic proteomic markers of arteriosclerosis study. PLoS One (2010) 1.34
Association of adiponectin with mortality in older adults: the Health, Aging, and Body Composition Study. Diabetologia (2009) 1.19
Adipose tissue density, a novel biomarker predicting mortality risk in older adults. J Gerontol A Biol Sci Med Sci (2013) 1.18
Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study. Arch Neurol (2012) 1.17
Associations of total and high-molecular-weight adiponectin with all-cause and cardiovascular mortality in older persons: the Cardiovascular Health Study. Circulation (2012) 1.14
Globular adiponectin, acting via AdipoR1/APPL1, protects H9c2 cells from hypoxia/reoxygenation-induced apoptosis. PLoS One (2011) 1.13
Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women. Atherosclerosis (2011) 1.11
Longitudinal changes in adiponectin and inflammatory markers and relation to survival in the oldest old: the Cardiovascular Health Study All Stars study. J Gerontol A Biol Sci Med Sci (2011) 1.09
Adiponectin and all-cause mortality in elderly people with type 2 diabetes. Diabetes Care (2012) 1.07
Change in circulating adiponectin in advanced old age: determinants and impact on physical function and mortality. The Cardiovascular Health Study All Stars Study. J Gerontol A Biol Sci Med Sci (2010) 1.04
Associations of adiponectin and leptin with incident coronary heart disease and ischemic stroke in african americans: the jackson heart study. Front Public Health (2013) 1.02
Relationships between serum adiponectin with metabolic syndrome and components of metabolic syndrome in non-diabetic Koreans: ARIRANG study. Yonsei Med J (2011) 1.00
The usefulness of circulating adipokine levels for the assessment of obesity-related health problems. Int J Med Sci (2008) 0.99
Androgen deprivation therapy and risk for diabetes and cardiovascular disease in prostate cancer survivors. Curr Urol Rep (2008) 0.94
High-molecular-weight and total adiponectin levels and incident symptomatic peripheral artery disease in women: a prospective investigation. Circulation (2011) 0.93
Associations of SNPs in ADIPOQ and subclinical cardiovascular disease in the multi-ethnic study of atherosclerosis (MESA). Obesity (Silver Spring) (2010) 0.93
Causal relationship between adiponectin and metabolic traits: a Mendelian randomization study in a multiethnic population. PLoS One (2013) 0.92
Direct effects of adipokines on the heart: focus on adiponectin. Heart Fail Rev (2013) 0.92
Variants in the adiponectin gene and serum adiponectin: the Coronary Artery Development in Young Adults (CARDIA) Study. Obesity (Silver Spring) (2010) 0.91
Metabolic and hormonal changes induced by pioglitazone in polycystic ovary syndrome: a randomized, placebo-controlled clinical trial. J Clin Endocrinol Metab (2008) 0.89
F2-isoprostanes and adiposity in older adults. Obesity (Silver Spring) (2010) 0.86
Association between polymorphisms in the adiponectin gene and cardiovascular disease: a meta-analysis. BMC Med Genet (2012) 0.86
Is adiponectin a bystander or a mediator in heart failure? The tangled thread of a good-natured adipokine in aging and cardiovascular disease. Heart Fail Rev (2010) 0.86
Effects of flaxseed oil supplementation on plasma adiponectin levels in dyslipidemic men. Eur J Nutr (2007) 0.84
Adiponectin, leptin, and chemerin in elderly patients with type 2 diabetes mellitus: a close linkage with obesity and length of the disease. Biomed Res Int (2014) 0.83
Association between adiponectin and heart failure risk in the physicians' health study. Obesity (Silver Spring) (2013) 0.83
Gender differences in adiponectin levels and body composition in older adults: Hallym aging study. BMC Geriatr (2014) 0.82
Effects of tesamorelin on inflammatory markers in HIV patients with excess abdominal fat: relationship with visceral adipose reduction. AIDS (2011) 0.82
Relationship between epicardial adipose tissue, coronary artery disease and adiponectin in a Mexican population. Cardiovasc Ultrasound (2014) 0.82
Lower total and percent of high-molecular-weight adiponectin concentration in South Asian kidney transplant recipients. Clin Kidney J (2012) 0.80
Is adiponectin associated with acute myocardial infarction in Iranian non obese patients? Lipids Health Dis (2009) 0.80
Relationship between plasma adiponectin level with inflammatory and metabolic markers in patients with chronic kidney disease. Nephrourol Mon (2013) 0.80
Relation of Adiponectin to All-Cause Mortality, Cardiovascular Mortality, and Major Adverse Cardiovascular Events (from the Dallas Heart Study). Am J Cardiol (2015) 0.80
Adiponectin is associated with risk of the metabolic syndrome and insulin resistance in women. Acta Diabetol (2010) 0.79
Single nucleotide polymorphism rs3774261 in the AdipoQ gene is associated with the risk of coronary heart disease (CHD) in Northeast Han Chinese population: a case-control study. Lipids Health Dis (2016) 0.79
High adiponectin levels fail to protect against the risk of hypertension and, in women, against coronary disease: involvement in autoimmunity? World J Diabetes (2013) 0.78
The role of serum magnesium and calcium on the association between adiponectin levels and all-cause mortality in end-stage renal disease patients. PLoS One (2012) 0.77
Serum adiponectin and cardiometabolic risk in patients with acute coronary syndromes. Arq Bras Cardiol (2013) 0.77
Total adiponectin and risk of symptomatic lower extremity peripheral artery disease in men. Arterioscler Thromb Vasc Biol (2013) 0.77
Drugs that reverse disease transcriptomic signatures are more effective in a mouse model of dyslipidemia. Mol Syst Biol (2015) 0.76
Drugs that reverse disease transcriptomic signatures are more effective in a mouse model of dyslipidemia. Mol Syst Biol (2015) 0.76
Adiponectin and risk of vascular events in the Northern Manhattan study. Atherosclerosis (2012) 0.76
Leptin and adiponectin as predictors of cardiovascular risk after gestational diabetes mellitus. Cardiovasc Diabetol (2017) 0.76
AMPK Activators as a Drug for Diabetes, Cancer and Cardiovascular Disease. Pharm Regul Aff (2014) 0.75
Insulin resistance, adiponectin and adverse outcomes following elective cardiac surgery: a prospective follow-up study. J Cardiothorac Surg (2010) 0.75
Plasma adiponectin level and myocardial infarction: the JMS Cohort Study. J Epidemiol (2009) 0.75
Adiponectin is not associated with blood pressure in normotensives and untreated hypertensives with normal kidney function. Medicine (Baltimore) (2014) 0.75
Obesity, Serum Resistin and Leptin Levels Linked to Coronary Artery Disease. Arq Bras Cardiol (2016) 0.75
Adiponectin deficiency blunts hypoxia-induced mobilization and homing of circulating angiogenic cells. Stem Cells Int (2013) 0.75
Adiponectin circulating levels and 10-year (2002-2012) cardiovascular disease incidence: the ATTICA Study. Endocrine (2017) 0.75
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem (1972) 95.79
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation (2002) 76.93
Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol (2000) 9.85
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med (2002) 8.95
Adiponectin and adiponectin receptors. Endocr Rev (2005) 8.46
Plasma adiponectin levels and risk of myocardial infarction in men. JAMA (2004) 7.46
Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia (2003) 5.91
Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol (2003) 4.86
Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem (2002) 4.79
The hypertension detection and follow-up program: Hypertension detection and follow-up program cooperative group. Prev Med (1976) 3.57
Adiponectin acts in the brain to decrease body weight. Nat Med (2004) 3.47
Adiponectin: more than just another fat cell hormone? Diabetes Care (2003) 3.30
Adiponectin--journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med (2005) 3.29
Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst (2005) 3.22
Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation (2005) 2.81
Adiponectin and breast cancer risk. J Clin Endocrinol Metab (2004) 2.72
A simplified method of calculating an overall goodness-of-fit test for the Cox proportional hazards model. Lifetime Data Anal (1998) 2.55
Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes (2004) 2.51
Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol (2002) 2.46
Adiponectin as a biomarker of the metabolic syndrome. Circ J (2004) 2.22
Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers. Eur Heart J (2005) 2.16
Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab (2002) 2.04
Adiponectin acts as an endogenous antithrombotic factor. Arterioscler Thromb Vasc Biol (2005) 1.88
Adipocytokines: leptin--the classical, resistin--the controversical, adiponectin--the promising, and more to come. Best Pract Res Clin Endocrinol Metab (2005) 1.87
Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab (2004) 1.86
Diurnal and ultradian dynamics of serum adiponectin in healthy men: comparison with leptin, circulating soluble leptin receptor, and cortisol patterns. J Clin Endocrinol Metab (2003) 1.84
Independent circadian and sleep/wake regulation of adipokines and glucose in humans. J Clin Endocrinol Metab (2005) 1.81
Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women. J Clin Endocrinol Metab (2005) 1.74
Plasma adiponectin levels and five-year survival after first-ever ischemic stroke. Stroke (2005) 1.70
Adiponectin: stability in plasma over 36 hours and within-person variation over 1 year. Clin Chem (2003) 1.70
Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo. Diabetes Care (2005) 1.62
Plasma adiponectin and gastric cancer. Clin Cancer Res (2005) 1.62
Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity. Proc Natl Acad Sci U S A (2004) 1.61
Adiponectin and coronary heart disease: the Strong Heart Study. Arterioscler Thromb Vasc Biol (2005) 1.45
The relationship between weight loss and all-cause mortality in older men and women with and without diabetes mellitus: the Rancho Bernardo study. J Am Geriatr Soc (2002) 1.31
Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. Diabetes Care (2002) 1.24
Central actions of adipocyte hormones. Trends Endocrinol Metab (2005) 1.17
Dual roles of adiponectin/Acrp30 in vivo as an anti-diabetic and anti-atherogenic adipokine. Curr Drug Targets Immune Endocr Metabol Disord (2003) 1.10
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 101.79
Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet (2008) 35.06
Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89
Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet (2010) 16.96
Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet (2012) 11.09
Variants in MTNR1B influence fasting glucose levels. Nat Genet (2008) 10.85
Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men. Contemp Clin Trials (2005) 9.57
Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care (2007) 8.43
Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet (2012) 7.59
Birth weight and risk of type 2 diabetes: a systematic review. JAMA (2008) 6.73
Trial of Continuous or Interrupted Chest Compressions during CPR. N Engl J Med (2015) 6.66
Effects of Testosterone Treatment in Older Men. N Engl J Med (2016) 6.66
Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet (2010) 6.66
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2003) 5.38
Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ (2005) 5.34
High-trauma fractures and low bone mineral density in older women and men. JAMA (2007) 5.00
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet (2012) 4.87
Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet (2012) 4.73
A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet (2012) 4.37
Low serum testosterone and mortality in older men. J Clin Endocrinol Metab (2007) 4.27
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet (2014) 4.13
Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene. J Natl Cancer Inst (2004) 4.09
Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. Diabetes (2010) 4.07
Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med (2004) 3.93
Lipid-related markers and cardiovascular disease prediction. JAMA (2012) 3.91
Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study. Lancet (2013) 3.87
Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet (2013) 3.25
Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21
Frailty in older men: prevalence, progression, and relationship with mortality. J Am Geriatr Soc (2007) 3.15
New gene functions in megakaryopoiesis and platelet formation. Nature (2011) 3.14
Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA (2002) 3.13
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet (2012) 3.04
Mortality in adults aged 26-54 years related to socioeconomic conditions in childhood and adulthood: post war birth cohort study. BMJ (2002) 2.93
Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet (2013) 2.92
Out-of-hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Ann Surg (2011) 2.85
Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet (2013) 2.83
Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program. Diabetes (2005) 2.80
Seventy-five genetic loci influencing the human red blood cell. Nature (2012) 2.77
Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet (2011) 2.73
Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care (2007) 2.71
Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med (2002) 2.69
Testosterone and estradiol among older men. J Clin Endocrinol Metab (2005) 2.63
Prevalence of angina in women versus men: a systematic review and meta-analysis of international variations across 31 countries. Circulation (2008) 2.56
Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. Am J Clin Nutr (2008) 2.55
Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance. Diabetes (2005) 2.46
Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study. Am J Epidemiol (2013) 2.44
Ethnic differences in visceral adipose tissue and type 2 diabetes: Filipino, African-American, and white women. Obes Res (2005) 2.44
Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans. Diabetes (2010) 2.44
Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes (2012) 2.43
Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factors. Circulation (2009) 2.41
Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol (2002) 2.41
Risk factors and secondary prevention in women with heart disease: the Heart and Estrogen/progestin Replacement Study. Ann Intern Med (2003) 2.40
A1C and diabetes diagnosis: The Rancho Bernardo Study. Diabetes Care (2009) 2.36
The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes. J Gerontol A Biol Sci Med Sci (2006) 2.35
Stratifying type 2 diabetes cases by BMI identifies genetic risk variants in LAMA1 and enrichment for risk variants in lean compared to obese cases. PLoS Genet (2012) 2.34
Perishock pause: an independent predictor of survival from out-of-hospital shockable cardiac arrest. Circulation (2011) 2.31
Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care (2002) 2.28
Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA. J Infect Dis (2006) 2.26
Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study. J Am Coll Cardiol (2008) 2.26
Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes (2011) 2.21
Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch Intern Med (2007) 2.17
Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. Nat Genet (2012) 2.15
Report of a National Heart, Lung, And Blood Institute Workshop: heterogeneity in cardiometabolic risk in Asian Americans In the U.S. Opportunities for research. J Am Coll Cardiol (2010) 2.15
Interactions of dietary whole-grain intake with fasting glucose- and insulin-related genetic loci in individuals of European descent: a meta-analysis of 14 cohort studies. Diabetes Care (2010) 2.14
Vitamin D deficiency in older men. J Clin Endocrinol Metab (2009) 2.13
The burden of urinary incontinence and urinary bother among elderly prostate cancer survivors. Eur Urol (2013) 2.10
Type 2 diabetes and metabolic syndrome in Filipina-American women : a high-risk nonobese population. Diabetes Care (2002) 2.10
A genome-wide association study reveals variants in ARL15 that influence adiponectin levels. PLoS Genet (2009) 2.09
Decreased slow wave sleep increases risk of developing hypertension in elderly men. Hypertension (2011) 2.09
Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro. J Infect Dis (2008) 2.08
Sex differences in the association between proinsulin and intact insulin with coronary heart disease in nondiabetic older adults: the Rancho Bernardo Study. Circulation (2002) 2.06
Birth weight, components of height and coronary heart disease: evidence from the Whitehall II study. Int J Epidemiol (2006) 2.04
Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: the Rancho Bernardo Study. Metabolism (2002) 2.04
Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study. Am J Med (2002) 2.02
Out-of-hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA (2010) 2.00
Validity of a short questionnaire to assess physical activity in 10 European countries. Eur J Epidemiol (2011) 1.95
Serum uric acid levels improve prediction of incident type 2 diabetes in individuals with impaired fasting glucose: the Rancho Bernardo Study. Diabetes Care (2009) 1.95
Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med (2004) 1.95
Predictors of non-spine fracture in elderly men: the MrOS study. J Bone Miner Res (2007) 1.93
Hyperkyphotic posture and risk of future osteoporotic fractures: the Rancho Bernardo study. J Bone Miner Res (2005) 1.89
Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes. Circulation (2011) 1.88
Genetic markers of adult obesity risk are associated with greater early infancy weight gain and growth. PLoS Med (2010) 1.88
Walking decreased risk of cardiovascular disease mortality in older adults with diabetes. J Clin Epidemiol (2006) 1.86
Hyperkyphotic posture predicts mortality in older community-dwelling men and women: a prospective study. J Am Geriatr Soc (2004) 1.86
Plasma neutrophil gelatinase-associated lipocalin is independently associated with cardiovascular disease and mortality in community-dwelling older adults: The Rancho Bernardo Study. J Am Coll Cardiol (2012) 1.84
Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol (2005) 1.83
Factors associated with the lumbar spine and proximal femur bone mineral density in older men. Osteoporos Int (2005) 1.82
Obesity increases and physical activity decreases lower urinary tract symptom risk in older men: the Osteoporotic Fractures in Men study. Eur Urol (2011) 1.81
High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden. J Am Coll Cardiol (2011) 1.81
Vasomotor symptoms and mortality: the Rancho Bernardo Study. Menopause (2009) 1.80
Isoflavones and cognitive function in older women: the SOy and Postmenopausal Health In Aging (SOPHIA) Study. Menopause (2003) 1.77
Association of endogenous sex hormones and insulin resistance among postmenopausal women: results from the Postmenopausal Estrogen/Progestin Intervention Trial. J Clin Endocrinol Metab (2003) 1.76
Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and Older: results from the National Osteoporosis Risk Assessment (NORA). J Bone Miner Res (2004) 1.76
Predictors of heart failure among women with coronary disease. Circulation (2004) 1.74
Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. Nat Genet (2013) 1.72
Endogenous testosterone levels, physical performance, and fall risk in older men. Arch Intern Med (2006) 1.72
A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One (2012) 1.72